Tag:
BioMerieux
Latest Headlines
Latest Headlines
Biocartis banks $100M C round for diagnostics work
Ramping up a new product that promises to put some cutting-edge diagnostics technology in the field by 2013, Switzerland's Biocartis has rounded up a huge $100 million C round from a long list of
BioMerieux snares stake in Knome
France's BioMerieux has acquired a 10 percent stake in Knome for $5 million and struck a deal to use the Cambridge, MA-based company's genome sequencing and analysis services. "The deal with Knome
ExonHit, bioMerieux nix colon cancer program
French drugmakers ExonHit Therapeutics and bioMérieux have decided against pursuing their collaboration in colon cancer after a recent review of data by a scientific committee. Both companies
